Petar Antunović

2.0k total citations · 1 hit paper
26 papers, 1.2k citations indexed

About

Petar Antunović is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Petar Antunović has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 11 papers in Public Health, Environmental and Occupational Health and 10 papers in Molecular Biology. Recurrent topics in Petar Antunović's work include Acute Myeloid Leukemia Research (22 papers), Acute Lymphoblastic Leukemia research (11 papers) and Retinoids in leukemia and cellular processes (5 papers). Petar Antunović is often cited by papers focused on Acute Myeloid Leukemia Research (22 papers), Acute Lymphoblastic Leukemia research (11 papers) and Retinoids in leukemia and cellular processes (5 papers). Petar Antunović collaborates with scholars based in Sweden, Denmark and Norway. Petar Antunović's co-authors include Martin Höglund, Lars Möllgård, Gunnar Juliusson, Anders Wåhlin, Åsa Rangert Derolf, Dick Stockelberg, Sylvain Lehmann, Ulf Tidefelt, Sören Lehmann and Vladimir Lazarević and has published in prestigious journals such as Blood, Cancer and Clinical Cancer Research.

In The Last Decade

Petar Antunović

25 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

2008 683 citations Gunnar Juliusson, Petar Antunović et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Petar Antunović Sweden	12	1.1k	464	383	313	248	26	1.2k
Jan Maxwell Nørgaard Denmark	17	724 0.7×	340 0.7×	298 0.8×	229 0.7×	223 0.9×	48	922
Ching-Yuan Kuo Taiwan	5	764 0.7×	494 1.1×	226 0.6×	182 0.6×	156 0.6×	10	948
C. Michel Zwaan Netherlands	17	689 0.6×	349 0.8×	323 0.8×	186 0.6×	167 0.7×	36	992
Ruth Heaton United States	5	684 0.6×	337 0.7×	72 0.2×	284 0.9×	108 0.4×	8	847
RM Stone United States	9	570 0.5×	282 0.6×	469 1.2×	123 0.4×	215 0.9×	13	940
R. Schlenk Germany	10	473 0.4×	183 0.4×	180 0.5×	139 0.4×	96 0.4×	20	629
A. Kuendgen Germany	10	572 0.5×	232 0.5×	90 0.2×	296 0.9×	59 0.2×	22	690
Mario Annunziata Italy	17	592 0.5×	202 0.4×	146 0.4×	255 0.8×	141 0.6×	51	776
J O Moore United States	9	436 0.4×	148 0.3×	169 0.4×	126 0.4×	102 0.4×	9	600
O. Krieger Austria	13	375 0.3×	123 0.3×	85 0.2×	253 0.8×	144 0.6×	41	600

Countries citing papers authored by Petar Antunović

Since Specialization

Citations

This map shows the geographic impact of Petar Antunović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petar Antunović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petar Antunović more than expected).

Fields of papers citing papers by Petar Antunović

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petar Antunović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petar Antunović. The network helps show where Petar Antunović may publish in the future.

Co-authorship network of co-authors of Petar Antunović

This figure shows the co-authorship network connecting the top 25 collaborators of Petar Antunović. A scholar is included among the top collaborators of Petar Antunović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petar Antunović. Petar Antunović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eriksson, Anna, Martin Jädersten, Vladimir Lazarević, et al.. (2022). A risk score based on real-world data to predict early death in acute promyelocytic leukemia. Haematologica. 107(7). 1528–1537. 12 indexed citations

Nilsson, Christer, Erik Hulegårdh, Hege Garelius, et al.. (2022). Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications. Haematologica. 108(4). 1015–1025. 21 indexed citations

Creignou, Maria, Elsa Bernard, Michael J. Crowther, et al.. (2022). Transfusion Patterns during Early Follow-up Predict Overall Survival Independently of IPSS-M in Patients with Myelodysplastic Syndromes. Blood. 140(Supplement 1). 6968–6970. 1 indexed citations

Rosso, Aldana, Gunnar Juliusson, Fryderyk Lorenz, et al.. (2021). Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? A population-based study. Leukemia & lymphoma. 62(8). 1973–1981. 4 indexed citations

Juliusson, Gunnar, Martin Jädersten, Stefan Deneberg, et al.. (2020). The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting. Blood Advances. 4(6). 1094–1101. 47 indexed citations

Folkvaljon, Yasin, Johan Sundberg, Mats Lambe, et al.. (2018). Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population‐based setting: a report from the Swedish MDS register. British Journal of Haematology. 181(5). 614–627. 30 indexed citations

Lazarević, Vladimir, Aldana Rosso, Gunnar Juliusson, et al.. (2017). Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population‐based study from the Swedish AML registry. European Journal Of Haematology. 98(5). 493–500. 10 indexed citations

Lazarević, Vladimir, Aldana Rosso, Gunnar Juliusson, et al.. (2015). Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia. American Journal of Hematology. 90(9). 800–805. 14 indexed citations

Lazarević, Vladimir, Bertil Johansson, Petar Antunović, et al.. (2014). Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population‐based series of acute myeloid leukaemia. European Journal Of Haematology. 94(5). 419–423. 11 indexed citations

10.

Hulegårdh, Erik, Christer Nilsson, Vladimir Lazarević, et al.. (2014). Characterization and prognostic features of secondary acute myeloid leukemia in a population‐based setting: A report from the Swedish Acute Leukemia Registry. American Journal of Hematology. 90(3). 208–214. 172 indexed citations

11.

Nilsson‐Ehle, Herman, Gunnar Birgegård, Jan Samuelsson, et al.. (2011). Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions. European Journal Of Haematology. 87(3). 244–252. 49 indexed citations

12.

Juliusson, Gunnar, Karin Karlsson, Vladimir Lazarević, et al.. (2011). Hematopoietic stem cell transplantation rates and long‐term survival in acute myeloid and lymphoblastic leukemia. Cancer. 117(18). 4238–4246. 46 indexed citations

13.

Grövdal, Michael, Mohsen Karimi, Anni Aggerholm, et al.. (2010). Maintenance treatment with azacytidine for patients with high‐risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy. British Journal of Haematology. 150(3). 293–302. 44 indexed citations

14.

Juliusson, Gunnar, Lars Möllgård, Sören Lehmann, et al.. (2009). Proportion of Adult AML Patient Population Receiving Allogeneic Stem Cell Transplantation and Long-Term Outcome: Real World Data From the Swedish National Acute Leukemia Registry.. Blood. 114(22). 2289–2289. 3 indexed citations

15.

Juliusson, Gunnar, Petar Antunović, Åsa Rangert Derolf, et al.. (2008). Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood. 113(18). 4179–4187. 683 indexed citations breakdown →

16.

Grövdal, Michael, Anni Aggerholm, Petar Antunović, et al.. (2007). Maintenance Treatment with Azacytidine for Patients with High Risk Myelodysplastic Syndromes or Acute Myeloid Leukaemia in Complete Remission after Intensive Chemotherapy.. Blood. 110(11). 818–818. 5 indexed citations

17.

Miljić, Predrag, et al.. (2000). Recurrent venous thrombosis in a patient with chronic lymphocytic leukemia and acquired protein S deficiency. PubMed. 30(1). 51–54. 4 indexed citations

18.

Antunović, Petar, et al.. (1998). Familial Myelodysplastic Syndrome/Acute Myeloid Leukaemia With Monosomy 7: Report of a New Kindred. Hematology. 3(1). 31–36. 1 indexed citations

19.

Basara, Nadežda, et al.. (1996). Megakaryocyte progenitors in paroxysmal nocturnal haemoglobinuria are sensitive to complement. European Journal Of Haematology. 57(3). 227–229. 1 indexed citations

20.

Basara, Nadežda, et al.. (1996). The Inhibitory Effect of Human Macrophage Inflammatory Protein‐1α (LD78) on Acute Myeloid Leukemia Cells in Vitro. Stem Cells. 14(4). 445–451. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact